0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-03 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 15613393 2024-04-03 2025-04-30 15613393 2025-04-30 15613393 2024-04-02 15613393 bus:Director1 2024-04-03 2025-04-30 15613393 core:WithinOneYear 2025-04-30 15613393 core:ShareCapital 2025-04-30 15613393 core:RetainedEarningsAccumulatedLosses 2025-04-30 15613393 bus:SmallEntities 2024-04-03 2025-04-30 15613393 bus:AuditExemptWithAccountantsReport 2024-04-03 2025-04-30 15613393 bus:SmallCompaniesRegimeForAccounts 2024-04-03 2025-04-30 15613393 bus:PrivateLimitedCompanyLtd 2024-04-03 2025-04-30 15613393 bus:FullAccounts 2024-04-03 2025-04-30
COMPANY REGISTRATION NUMBER: 15613393

ELB Bloodstock Limited

Filleted Unaudited Financial Statements

For the period ended

30 April 2025

ELB Bloodstock Limited

Statement of Financial Position

30 April 2025

| 30 Apr 25
Note | £ | £

Current assets

Stocks | 4,507,280 |
Debtors | 4 | 106,152 |
Cash at bank and in hand | 936,120 |
| ------------ |
| 5,549,552 |

Creditors: amounts falling due within one year | 5 | 4,971,591 |
| ------------ |
Net current assets |  | 577,961
|  | ---------
Total assets less current liabilities |  | 577,961
|  | ---------
Net assets |  | 577,961
|  | ---------

Capital and reserves

Called up share capital |  | 1
Profit and loss account |  | 577,960
|  | ---------
Shareholders funds |  | 577,961
|  | ---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 27 March 2026 , and are signed on behalf of the board by:

Miss E L Banks |
Director |

Company registration number: 15613393

ELB Bloodstock Limited

Notes to the Financial Statements

Period from 3 April 2024 to 30 April 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lushington House, 119 High Street, Newmarket, Suffolk, CB8 9AE, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The company is financed by the director and they have confirmed they intend to support the company for the foreseeable future. The director believes the company is therefore a going concern.
Revenue recognition
Turnover is measured at the fair value of consideration received or receivable in respect of prize money, sponsorship and sale of bloodstock and recharges which are net of discounts and Value Added Tax. Prize money is recognised on receipt from the British Horse Association. Sponsorship income is recognised on receipt from the British Horse Association or per the contract agreement. Sponsorship income is deferred if the contract period differs to the accounting year end. Sale of bloodstock income is recognised when the ownership of bloodstock passes from the seller to the buyer.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Stocks
Stock comprises bloodstock (mares and foals) held for the purposes of breeding and racing. Such assets are stated at the lower of cost and net realisable value (selling price less costs to sell). Where a write down is identified, the value of the stock is reduced and the reduction immediately charged in the profit and loss account. A transfer is made between breeding and racing when the purpose of the bloodstock changes. The transfer value is based on the net realisable value of the bloodstock as at the date of transfer.
4. Debtors

| 30 Apr 25
| £
Trade debtors | 1,211
Other debtors | 104,941
| ---------
| 106,152
| ---------

5. Creditors: amounts falling due within one year

| 30 Apr 25
| £
Trade creditors | 64,961
Social security and other taxes | 313,005
Other creditors | 4,593,625
| ------------
| 4,971,591
| ------------

6. Employee numbers
The average number of persons employed by the company during the period amounted to nil.